Updates
** Shares of Australia's ALS Limited ALQ.AX down nearly 1% at A$17.565
** Mineral testing services provider to report FY25 results on May 27
** Jefferies maintains "buy" rating at PT A$18.80
** Brokerage says ALQ's biggest segment, minerals, has become a positive driver after being a drag on the company for most of FY24 and FY25
** Expects signs for medium-term growth in results
** However, Jarden downgrades ALS to "underweight" from "neutral"
** Brokerage anticipates some positive commentary on co's commodities division over strengthening volume growth, but believes its share price reflects potential upsides
** It marginally hikes PT to A$15 from A$14.5 to reflect expected modest EPS uplift by nearly 1% for FY26 and FY27
** Stock up 16.6% YTD, including current session's moves
(Reporting by Roshan Thomas and Nikita Maria Jino in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.